These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4649341)

  • 21. The inhibition of dihydrofolate reductase by folate analogues: structural requirements for slow- and tight-binding inhibition.
    Williams JW; Duggleby RG; Cutler R; Morrison JF
    Biochem Pharmacol; 1980 Feb; 29(4):589-95. PubMed ID: 7370052
    [No Abstract]   [Full Text] [Related]  

  • 22. Activation of L-valyl-tRNA synthetase from rat liver by monovalent cations.
    Romano M; Cerra M; Lombardi ML
    Ital J Biochem; 1974 Jan; 23(1):19-28. PubMed ID: 4829142
    [No Abstract]   [Full Text] [Related]  

  • 23. Adamantyl analogs of 2'-(3-dimethylaminopropylthio)cinnamanilide.
    Narayanan VL
    J Med Chem; 1972 Nov; 15(11):1180-2. PubMed ID: 4654670
    [No Abstract]   [Full Text] [Related]  

  • 24. [NADP analogs, inhibitors of dihydrofolate reductase].
    Belousova AK; Zilber IuA
    Biokhimiia; 1973; 38(5):1083-8. PubMed ID: 4149967
    [No Abstract]   [Full Text] [Related]  

  • 25. Different salt concentration requirement of nuclear and cytoplasmic Mn++-stimulated poly(A) synthetase activities from rat liver.
    Corti A; Rossini GP; Drusiani F
    Experientia; 1977 Jun; 33(6):713-4. PubMed ID: 891720
    [No Abstract]   [Full Text] [Related]  

  • 26. Adamantyl analogs of the antidepressive, 5-(2-dimethylaminoethyl)-2,3-dihydro-2-phenyl-1,5-benzothiazepin-4(5H)-one.
    Narayanan VL
    J Med Chem; 1972 Jun; 15(6):682-4. PubMed ID: 5030939
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of univalent cations on activities catalyzed by bovine-liver propionyl-CoA carboxylase.
    Giorgio AJ; Plaut GW
    Biochim Biophys Acta; 1967 Jul; 139(2):487-501. PubMed ID: 6034687
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.
    Ferone R; Burchall JJ; Hitchings GH
    Mol Pharmacol; 1969 Jan; 5(1):49-59. PubMed ID: 4392112
    [No Abstract]   [Full Text] [Related]  

  • 29. Dihydrofolic reductase in human blood cells. I. Techniques for the study of enzyme activity and intracellular amethopterin content.
    Martelli MF; Tonato M; Grignani F
    Enzymol Biol Clin (Basel); 1967; 8(5):353-62. PubMed ID: 4383611
    [No Abstract]   [Full Text] [Related]  

  • 30. Similar characteristics of folate analogue transport in vitro in contrast to varying dihydrofolate reductase levels in epithelial cells at different stages of maturation in mouse small intestine.
    Sirotnak FM; Moccio DM; Yang CH
    Cancer Res; 1984 Nov; 44(11):5204-11. PubMed ID: 6488181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence and properties of dihydrofolate reductases within the genus Crithidia.
    Gutteridge WE; McCormack JJ; Jaffe JJ
    Biochim Biophys Acta; 1969 May; 178(3):453-8. PubMed ID: 4389070
    [No Abstract]   [Full Text] [Related]  

  • 32. Stabilization of dihydrofolate reductase by inhibitors in vivo and in vitro.
    Hillcoat BL; Marshall L; Gauldie J; Hiebert M
    Ann N Y Acad Sci; 1971 Nov; 186():187-208. PubMed ID: 4332034
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis and biological activity of 2,4-diamino-6- and -7-(1-adamantyl)pteridines.
    Jonak JP; Zakrzewski SF; Mead LH; Allshouse LD
    J Med Chem; 1972 Dec; 15(12):1331-2. PubMed ID: 4629014
    [No Abstract]   [Full Text] [Related]  

  • 34. Isolation and properties of a Mn2+-activated phosphohistone phosphatase from canine heart.
    Li HC; hsiao KJ
    Arch Biochem Biophys; 1977 Feb; 179(1):147-56. PubMed ID: 14591
    [No Abstract]   [Full Text] [Related]  

  • 35. Improved purification of tetrahydrofolate dehydrogenase from L1210 leukemia by affinity chromatography.
    Chello PL; Cashmore AR; Jacobs SA; Bertino JR
    Biochim Biophys Acta; 1972 Apr; 268(1):30-4. PubMed ID: 5018279
    [No Abstract]   [Full Text] [Related]  

  • 36. Purification and properties of Escherichia coli dihydrofolate reductase.
    Baccanari D; Phillips A; Smith S; Sinski D; Burchall J
    Biochemistry; 1975 Dec; 14(24):5267-73. PubMed ID: 46
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of codon 22 mutations on substrate and inhibitor binding for human dihydrofolate reductase.
    Ercikan E; Waltham M; Dicker A; Schweitzer B; Bertino JR
    Adv Exp Med Biol; 1993; 338():515-9. PubMed ID: 8304170
    [No Abstract]   [Full Text] [Related]  

  • 38. Human dihydrofolate reductase: reduction of alternative substrates, pH effects, and inhibition by deazafolates.
    Williams EA; Morrison JF
    Biochemistry; 1992 Jul; 31(29):6801-11. PubMed ID: 1637816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of dihydrofolate reductase from Mycobacterium phlei.
    Al-Rubeai M; Dale JW
    Biochem J; 1986 Apr; 235(1):301-3. PubMed ID: 3741386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analogs of tetrahydrofolic acid. 33. Hydrophobic bonding to dihydrofolic reductase V. Inhibition by some pyrimidines bridged to benzoic acid.
    Baker BR; Ho BT; Coward JK; Santi DV
    J Pharm Sci; 1966 Mar; 55(3):302-8. PubMed ID: 5960176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.